Annotation of SBML Models Through Rule-Based Semantic IntegrationAllyson Lister
This talk was given on June 28, 2009 at the Bio-Ontologies SIG as part of ISMB/ECCB 2009. You can download the paper this presentation is about from http://hdl.handle.net/10101/npre.2009.3286.1. More information on the ISMB conference is available at http://www.iscb.org/ismbeccb2009/ and http://friendfeed.com/ismbeccb2009
Annotation of SBML Models Through Rule-Based Semantic IntegrationAllyson Lister
This talk was given on June 28, 2009 at the Bio-Ontologies SIG as part of ISMB/ECCB 2009. You can download the paper this presentation is about from http://hdl.handle.net/10101/npre.2009.3286.1. More information on the ISMB conference is available at http://www.iscb.org/ismbeccb2009/ and http://friendfeed.com/ismbeccb2009
The life sciences domain has been one of the early adopters
of linked data and, a considerable portion of the Linked Open Data cloud is comprised of datasets from Life Sciences Linked Open Data (LSLOD). The deluge of biomedical data in the last few years, partially caused by the advent of high-throughput gene sequencing technologies, has been a primary motivation for these efforts. This success has lead to the growth in size of data sets and to the need for integrating multiples of these data-sets. This growth requires large scale distributed infrastructure and specific techniques for managing large linked data graphs. Especially in combination with Semantic Web and Linked Data technologies these promises to enable the processing of large as well as semantically heterogeneous data sources and the capturing of new knowledge from those. In this tutorial we present the state of the art in large data processing, as well as the amalgamation with Linked Data and Semantic Web technologies for better knowledge discovery and targeted applications. We aim to provide useful information for the Knowledge Acquisition research community as well as the working Data Scientist.
Tutorial at K-Cap 2015:
Knowledge Processing with Big Data and
Semantic Web Technologies.
Session 0: Motivation
Session 1: Infrastructure
Session 2: Data Curation
Session 3: Query Federation
Session 4: Analyze
Session 5: Visualization
Session 6: Hands On Session
DBpedia - An Interlinking Hub in the Web of DataChris Bizer
Given and overview about the DBpedia project and the role of DBpedia in the Web of Data and outlines the next steps from the Dbpedia project as well as ideas for using DBpedia data within the BBC.
A presentation about how data from Digimap has helped to find quarries used in the production of stone for Hadrian's Wall. The research was carried out by Kathleen O'Donnell as part of her MSC and will be continued in a PhD.
Data analysis & integration challenges in genomicsmikaelhuss
Presentation given at the Genomics Today and Tomorrow event in Uppsala, Sweden, 19 March 2015. (http://connectuppsala.se/events/genomics-today-and-tomorrow/) Topics include APIs, "querying by data set", machine learning.
Presented by Richard Kidd at "The Future Information Needs of Pharmaceutical & Medicinal Chemistry", Monday 28 November 2011 at The Linnean Society, Burlington Square, London run by the RSC CICAG group.
Semantic Web for Health Care and Biomedical InformaticsAmit Sheth
Amit Sheth, "Semantic Web for Health Care and Biomedical Informatics," Keynote at NSF Biomed Web Workshop, Corbett, Oregon, December 4-5, 2007.
http://www.biomedweb.info/2007/
The life sciences domain has been one of the early adopters
of linked data and, a considerable portion of the Linked Open Data cloud is comprised of datasets from Life Sciences Linked Open Data (LSLOD). The deluge of biomedical data in the last few years, partially caused by the advent of high-throughput gene sequencing technologies, has been a primary motivation for these efforts. This success has lead to the growth in size of data sets and to the need for integrating multiples of these data-sets. This growth requires large scale distributed infrastructure and specific techniques for managing large linked data graphs. Especially in combination with Semantic Web and Linked Data technologies these promises to enable the processing of large as well as semantically heterogeneous data sources and the capturing of new knowledge from those. In this tutorial we present the state of the art in large data processing, as well as the amalgamation with Linked Data and Semantic Web technologies for better knowledge discovery and targeted applications. We aim to provide useful information for the Knowledge Acquisition research community as well as the working Data Scientist.
Tutorial at K-Cap 2015:
Knowledge Processing with Big Data and
Semantic Web Technologies.
Session 0: Motivation
Session 1: Infrastructure
Session 2: Data Curation
Session 3: Query Federation
Session 4: Analyze
Session 5: Visualization
Session 6: Hands On Session
DBpedia - An Interlinking Hub in the Web of DataChris Bizer
Given and overview about the DBpedia project and the role of DBpedia in the Web of Data and outlines the next steps from the Dbpedia project as well as ideas for using DBpedia data within the BBC.
A presentation about how data from Digimap has helped to find quarries used in the production of stone for Hadrian's Wall. The research was carried out by Kathleen O'Donnell as part of her MSC and will be continued in a PhD.
Data analysis & integration challenges in genomicsmikaelhuss
Presentation given at the Genomics Today and Tomorrow event in Uppsala, Sweden, 19 March 2015. (http://connectuppsala.se/events/genomics-today-and-tomorrow/) Topics include APIs, "querying by data set", machine learning.
Presented by Richard Kidd at "The Future Information Needs of Pharmaceutical & Medicinal Chemistry", Monday 28 November 2011 at The Linnean Society, Burlington Square, London run by the RSC CICAG group.
Semantic Web for Health Care and Biomedical InformaticsAmit Sheth
Amit Sheth, "Semantic Web for Health Care and Biomedical Informatics," Keynote at NSF Biomed Web Workshop, Corbett, Oregon, December 4-5, 2007.
http://www.biomedweb.info/2007/
Short tutorials on how to use the web-based tool DAVID - Database for Annotation, Visualization and Integrated Discovery) - http://david.abcc.ncifcrf.gov/
DAVID provides a comprehensive set of functional annotation tools for investigators to understand biological meaning behind large list of genes.
Current advances to bridge the usability-expressivity gap in biomedical seman...Maulik Kamdar
I presented a talk at the Protege research meeting on the 'Current advances to bridge the usability-expressivity gap in biomedical semantic search (and visualizing linked data)' https://sites.google.com/site/protegeresearchmeeting/meeting-materials/current-advances-to-bridge-the-usability-expressivity-gap-in-semantic-search
Access to biomedical data is increasingly important to enable data driven science in the research community.
The Linked Open Data (LOD) principles (by Tim Berner-Lee) have been suggested to judge the quality of data by its accessibility (open data access), by its format and structures, and by its interoperability with other data sources.
The objective is to use interoperable data sources across the Web with ease.
The FAIR (findable, accessible, interoperable, reusable) data principles have been introduced for similar reasons with a stronger emphasis on achieving reusability.
In this presentation we assess the FAIR principles against the LOD principles to determine, to which degree, the FAIR principles reuse LOD principles, and to which degree they extend the LOD principles.
This assessment helps to clarify the relationship between both schemes and gives a better understanding, what extension FAIR represents in comparison to LOD.
We conclude, that LOD gives a clear mandate to the openness of data, whereas FAIR asks for a stated license for access and thus includes the concept of reusability under consideration of the license agreement.
Furthermore, FAIR makes strong reference to the contextual information required to improve reuse of the data, e.g., provenance information.
According to the LOD principles, such meta-data would be considered interoperable data as well, however, the requirement of extending of data with meta-data does indicate that FAIR is an extension of the LOD (in contrast to the inverse).
Quantifying the content of biomedical semantic resources as a core for drug d...Syed Muhammad Ali Hasnain
The biomedical research community is providing large-scale data sources to enable knowledge discovery from the data alone, or from novel scientific experiments in combination with the existing knowledge.
Increasingly semantic Web technologies are being developed and used including ontologies, triple stores and combinations thereof.
The amount of data is constantly increasing as well as the complexity of data.
Since the data sources are publicly available, the amount of content can be derived giving an overview on the accessible content but also on the state of the data representation in comparison to the existing content.
For a better understanding of the existing data resources, i.e.\ judgments on the distribution of data triples across concepts, data types and primary providers, we have performed a comprehensive analysis which delivers an overview on the accessible content for semantic Web solutions.
It can be derived that the information related to genes, proteins and chemical entities form the center, whereas the content related to diseases and pathways forms a smaller portion.
Further data relates to dietary content and specific questions such as cancer prevention and toxicological effects of drugs.
PROV has been adopted by a number of workflow systems for encoding the traces of workflow executions. Exploiting these provenance traces is hampered by two main impediments. Firstly, workflow systems extend PROV differently to cater for system-specific constructs. The difference between the adopted PROV extensions yields heterogeneity in the generated provenance traces. This heterogeneity diminishes the value of such traces, e.g. when combining and querying provenance traces of different workflow systems. Secondly, the provenance recorded by workflow systems tends to be large, and as such difficult to browse and understand by a human user. In this paper, we propose SHARP, a Linked Data approach for harmonizing cross-workflow provenance. The harmonization is performed by chasing tuple-generating and equality-generating dependencies defined for workflow provenance. This results in a provenance graph that can be summarized using domain-specific vocabularies. We experimentally evaluate the effectiveness of SHARP using a real-world omic experiment involving workflow traces generated by the Taverna and Galaxy systems.
SHARP is a Linked Data approach for harmonizing cross-workflow provenance. In this demo, we demonstrate SHARP through a real-world omic experiment involving workflow traces generated by Taverna and Galaxy systems.
SHARP starts by interlinking provenance traces generated by Galaxy and Taverna workflows and then harmonize the interlinked graphs thanks to OWL and PROV inference rules. The resulting provenance graph can be exploited for answering queries across Galaxy and Taverna workflow runs.
Exploiting Cognitive Computing and Frame Semantic Features for Biomedical Doc...Syed Muhammad Ali Hasnain
Nowadays, there are plenty of text documents in different domains that have unstructured content which makes them hard to analyze automatically. In particular, in the medical domain, this problem is even more stressed and is earning more and more attention. Medical reports may contain relevant information that can be employed, among many useful applications, to build predictive systems able to classify new medical cases thus supporting physicians to take more correct and reliable actions about diagnosis and cares. It is generally hard and time consuming inferring information for comparing unstructured data and evaluating similarities between various resources. In this work we show how it is possible to cluster medical reports, based on features detected by using two emerging tools, IBM Watson and Framester, from a collection of text documents. Experiments and results have proved the quality of the resulting clusterings and the key role that these services can play.
An Approach for Discovering and Exploring Semantic Relationships between GenesSyed Muhammad Ali Hasnain
This paper presents an approach for extracting, integrating and mining the annotations from a large corpus of gene summaries. It includes: i) a method for extracting annotations from several ontologies, mapping them into concepts and evaluating the semantic relatedness of genes, ii) the definition of a NoSQL graph database that leverages a loosely structured and multifaceted organization of data for storing concepts and their relationships, and iii) a mechanism to support the customized exploration of stored information. A prototype with a user-friendly interface fully enables users to visualize all concepts of their interest and to take advantage of their visualization for formulating biomedical hypotheses and discovering new knowledge.
A single interface for accessing life sciences (LS) data is a natural consequence to master the data deluge in this domain. The data in the LS requires integration and current integrative solutions increasingly rely on the federation of queries for distributed resources. We introduce a federated query processing system name ``BioFed", customised for LS-LOD. BioFed federates SPARQL queries over more than 130 public SPARQL endpoints.
Health care and life sciences research heavily relies on the ability to search, discover, formulate and correlate data from distinct sources. Over the last decade the deluge of health care life science data and the standardisation of linked data technologies resulted in publishing datasets of great importance. This emerged as an opportunity to explore new ways of bio-medical discovery through standardised interfaces.
Although the Semantic Web and Linked Data technologies help in dealing with data integration problem there remains a barrier adopting these for non-technical research audiences. In this paper we present FedViz, a visual interface for SPARQL query formulation and execution. FedViz is explicitly designed to increase intuitive data interaction from distributed sources and facilitates federated as well as non-federated SPARQL queries formulation. FedViz uses FedX for query execution and results retrieval. We also evaluate the usability of our system by using the standard system usability scale as well as a custom questionnaire, particularly designed to test the usability of the FedViz interface. Our overall usability score of 74.16 suggests that FedViz interface is easy to learn, consistent, and adequate for frequent use.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
2. We want to query the content, not the source
Proteins
Molecules
Genes
Diseases
3. A Linked Life Sciences Roadmap
Proteins
Molecules
Genes
Diseases
:Protein
:Molecule
:Gene
:Disease
Uniprot
PDB
Pfam PROSITE
ProDom
Uniref
UniPark Daily
medDrug
Bank ChemBL
Pub
Chem KEGG
Gene
Ontology
GeneID
Affy
metrix
Homo
gene
MGI
Disea
some
SIDER
4. 2- Possible Solutions
To assemble queries over multiple graphs at multiple endpoints,
either
vocabularies and ontologies are reused, Or
translation maps between different terminologies are created (“a posteriori
integration”)
6. Hypothesis
"Given a heterogeneous Life Sciences Linked Open Data
corpus, an active Compendium containing concepts from
distinct endpoints and properties connecting these
concepts, that can be (partially) leveraged to achieve "a
posteriori" integration"
7. Methodology
Cataloguing and Linking Life Sciences
LOD Cloud.
Ali Hasnain, Ronan Fox, Stefan Decker
and Helena F. Deus
18th International Conference on
Knowledge Engineering and Knowledge
Management (EKAW 8 - 12 October
2012), Galway, Ireland
10. BioFed: Federated Query Processing over Life
Sciences Linked Open Data
BioFed: Federated Query Processing
over Life Sciences Linked Open Data
Ali Hasnain, Qaiser Mehmood, Syeda
Sana e Zainab, Muhammad Saleem,
Claude Warren and Stefan Decker
JBMS-2015 (under review)
11. FedViz System Architecture
15
FedViz is an online application that
provides Biologist a flexible visual
interface to formulate and execute both
federated and non-federated,
SPARQL queries.
It translates the visually assembled
queries into SPARQL equivalent and
execute using query engine (FedX,
BioFed).
18. Conclusion and Future Work
• Cataloguing and Linking – Compendium of Life sciences
Datasets
• BioFed and FedViz a Particle Applications
• Improving Catalogue/ Adding Statistical/ Latency etc
information for customised and targeted query processing.
• Evaluating BioFed with other available Query Engines
including Anapsid, Splendid etc.